Next Quarterly Earnings
After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
STAAR Surgical develops, manufactures, and markets innovative implantable Collamer lenses (ICLs) for vision correction. The US-based company offers the EVO Visian ICL, a premium solution for patients with myopia and astigmatism. As a leading player in ophthalmology, STAAR Surgical revolutionizes medical technology for permanently sharp vision.
After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
STAAR Surgical is scheduled to report its next quarterly earnings on 11/04/2026. After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
STAAR Surgical last reported quarterly earnings on 8/12/2026 (Q2 2026). Earnings per share (EPS) came in at 0.16 USD.
Across its last 4 earnings reports, STAAR Surgical stock moved by ±10.2% on average the following day. The largest reaction was -24.7% on 02/11/2025; 3 of 4 reactions were positive.
STAAR Surgical has beaten analyst EPS estimates in 3 of its last 5 evaluated quarters (beat rate: 60%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 4 report dates (close to close).
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.